ArticleFrontiers in immunology2020

Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCT.

Mahinbanu Mammadli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.